Promega Corporation, 2800 Woods Hollow, Fitchburg, Wisconsin 53711, United States.
Promega Biosciences LLC, 277 Granada Drive, San Luis Obispo, California 93401, United States.
ACS Chem Biol. 2021 Feb 19;16(2):404-413. doi: 10.1021/acschembio.0c00987. Epub 2021 Feb 5.
Identification of physiologically relevant targets for lead compounds emerging from drug discovery screens is often the rate-limiting step toward understanding their mechanism of action and potential for undesired off-target effects. To this end, we developed a streamlined chemical proteomic approach utilizing a single, photoreactive cleavable chloroalkane capture tag, which upon attachment to bioactive compounds facilitates selective isolation of their respective cellular targets for subsequent identification by mass spectrometry. When properly positioned, the tag does not significantly affect compound potency and membrane permeability, allowing for binding interactions with the tethered compound (probe) to be established within intact cells under physiological conditions. Subsequent UV-induced covalent photo-cross-linking "freezes" the interactions between the probe and its cellular targets and prevents their dissociation upon cell lysis. Targets cross-linked to the capture tag are then efficiently enriched through covalent capture onto HaloTag coated beads and subsequent selective chemical release from the solid support. The tag's built-in capability for selective enrichment eliminates the need for ligation of a capture tag, thereby simplifying the workflow and reducing variability introduced through additional operational steps. At the same time, the capacity for adequate cross-linking without structural optimization permits modular assembly of photoreactive chloroalkane probes, which reduces the burden of customized chemistry. Using three model compounds, we demonstrate the capability of this approach to identify known and novel cellular targets, including those with low affinity and/or low abundance as well as membrane targets with several transmembrane domains.
从药物发现筛选中出现的铅化合物中鉴定出生理相关的靶标通常是理解其作用机制和潜在不良脱靶效应的限速步骤。为此,我们开发了一种简化的化学蛋白质组学方法,该方法利用单个光反应性可裂解氯烷捕获标签,该标签附着在生物活性化合物上,有助于选择性分离其各自的细胞靶标,然后通过质谱进行鉴定。当定位正确时,标签不会显著影响化合物的效力和膜通透性,允许在生理条件下在完整细胞内建立与连接化合物(探针)的结合相互作用。随后,UV 诱导的共价光交联“冻结”探针与其细胞靶标之间的相互作用,并防止其在细胞裂解时解离。然后,通过共价捕获到 HaloTag 包被的珠上,以及随后从固体支持物上选择性化学释放,有效地富集与捕获标签交联的靶标。标签内置的选择性富集能力消除了对捕获标签的连接的需要,从而简化了工作流程并减少了通过附加操作步骤引入的可变性。同时,无需结构优化即可进行充分交联的能力允许光反应性氯烷探针的模块化组装,从而减轻了定制化学的负担。使用三种模型化合物,我们证明了该方法识别已知和新型细胞靶标的能力,包括那些具有低亲和力和/或低丰度的靶标以及具有多个跨膜结构域的膜靶标。